IR-Center [zurück zur Startseite]
Evotec SE
Analyst Coverage
| Unternehmen | Analyst | Empfehlung | Target price of Shares listed at Frankfurt Stock Exchange (in EUR) | Target Price of ADS listed at NASDAQ New York (in USD) | Datum of latest Research Report |
| BofA | Derik de Bruin | UNDERPERFORM | 3.00 D | 06 November 2024 | |
| Bryan Garnier & Co | Bruno Bulic | BUY | 22.00 € | - | 10 July 2024 |
| Citigroup Inc. | Peter Verdult | BUY | 30.00 € | - | 22 May 2024 |
| TD Cowen | Brendan Smith | BUY | - | 10.00 D | 22 November 2024 |
| Deutsche Bank | Falko Friedrichs | SELL | 4.00 € | - | 22 November 2024 |
| H.C. Wainwright & Co. | Douglas Tsao | BUY | - | 8.00 D | 15 August 2024 |
| IntronHealth | Naresh Chouhan | SELL | 7.35 € | - | 17 June 2024 |
| Jefferies | Ben Jackson | HOLD | 6.80 € | 3.80 D | 15 November 2024 |
| ODDO BHF | Stephan Wulf | NEUTRAL | 7.50 € | - | 7 August 2024 |
| Royal Bank of Canada (RBC) | Charles Weston | OUTPERFOM | 11.60 € | - | 22 November 2024 |
| Rx Securities | Dr Samir Devani | BUY | 12.00 € | - | 06 November 2024 |
| Van Lanschot Kempen | Sebastiaan van der Schoot | BUY | 15.00 € | - | 7 August 2024 |
| Warburg Research | Dr Christian Ehmann | BUY | 14.00 € | - | 15 November 2024 |
| Average target price | 13.03 € | 6.20 D |
Diese Inhalte werden Ihnen präsentiert von unserem Kooperationspartner 